Pharming (PHAR) Assets Average (2021 - 2026)

Pharming's Assets Average history runs 6 years deep, the most recent figure standing at $494.7 million for Q1 2026.

• Quarterly Assets Average rose 23.18% year-over-year to $494.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $494.7 million (up 23.18% YoY) and the FY2025 annual result came in at $450.0 million, up 4.3% from the prior year.
• Assets Average was $494.7 million for Q1 2026 at Pharming, up from $486.9 million in the prior quarter.
• Across five years, Assets Average topped out at $191.4 billion in Q4 2022 and bottomed at $196.6 million in Q1 2022.
• A 5-year average of $22.9 billion and a median of $428.8 million in 2024 frame the typical range for Assets Average.
• Peak annual rise in Assets Average reached 95267.47% in 2022, while the deepest fall reached 99.91% in 2022.
• Pharming's Assets Average stood at $191.4 billion in 2022, then sank by 99.77% to $449.7 million in 2023, then decreased by 8.21% to $412.7 million in 2024, then advanced by 17.96% to $486.9 million in 2025, then increased by 1.6% to $494.7 million in 2026.
• Business Quant data shows PHAR's Assets Average at $494.7 million in Q1 2026, $486.9 million in Q4 2025, and $460.0 million in Q3 2025.